Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Non-Current Debt (2019 - 2025)

Cresco Labs' Non-Current Debt history spans 7 years, with the latest figure at $417.1 million for Q4 2025.

  • For Q4 2025, Non-Current Debt fell 9.47% year-over-year to $417.1 million; the TTM value through Dec 2025 reached $417.1 million, down 9.47%, while the annual FY2025 figure was $417.1 million, 9.47% down from the prior year.
  • Non-Current Debt reached $417.1 million in Q4 2025 per CRLBF's latest filing, down from $460.8 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $497.7 million in Q4 2023 to a low of $417.1 million in Q4 2025.
  • Average Non-Current Debt over 5 years is $463.5 million, with a median of $465.1 million recorded in 2021.
  • Peak YoY movement for Non-Current Debt: surged 82.07% in 2021, then decreased 9.47% in 2025.
  • A 5-year view of Non-Current Debt shows it stood at $465.1 million in 2021, then grew by 2.54% to $476.9 million in 2022, then grew by 4.37% to $497.7 million in 2023, then decreased by 7.43% to $460.8 million in 2024, then fell by 9.47% to $417.1 million in 2025.
  • Per Business Quant, the three most recent readings for CRLBF's Non-Current Debt are $417.1 million (Q4 2025), $460.8 million (Q4 2024), and $497.7 million (Q4 2023).